Drutz David 4
4 · Altimmune, Inc. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2023-03-23$4.27/sh+9,000$38,430→ 29,484 total(indirect: See Footnote)
Footnotes (4)
- [F1]Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.265 to $4.28, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 20,151 shares of Common Stock previously owned directly by the reporting person which were transferred to Pacific Biopharma Associates, LLC.
- [F4]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.